Last Updated on October 14, 2024 by The Health Master
Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of two (2) formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on based on the decision of 93rd Authority Meeting dated 15.11.2021 vide notification S.O. 4885(E) dated 26-11-2021.
NPPA, in its order on November, 26, listed the two (2) formulations for which it has fixed retail prices. A list of the formulations has been given below:
Formulations:
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceiling Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) |
| 1. | Methylthioninium chloride (Methylene blue) | Injection 10mg/ml | 1 ML | 21.85 |
| 2. | Hydroxocobalamin | Injection 1 mg/ml | 1 ML | 9.91 |
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
(c ) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(F) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Latest notifications – DPCO /NPPA
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NPPA fixes retail price of 47 formulations: November 2021
NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021
NPPA fixes retail price of 23 formulations: September 2021
NPPA fixes retail price of 1 formulation: September 2021
NPPA extends ceiling price regulation on Orthopaedic knee implants
NPPA extends price cap on LMO and Oxygen inhalation
Procedure to obtain license for Commercial Testing Laboratories
Govt asks States to collaborate with proposed Medical Devices Parks
Morepen gets USFDA nod for anti-allergy drug
Roche develops new research Test Kits for Omicron variant
Booster dose of these 6 Vaccines safe, increases immunity: Study
DGFT notifies norms for Sodium Salicylate & Methylcobalamin
NPPA to hire 33 professionals for various levels of its operations
Govt to amend Drug Rules for list of colours permitted to…
NPPA fixes retail price of 47 formulations: November 2021
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
